Gene · 5469
Papers2,516
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,516
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SETD7 Expression Is Associated with Breast Cancer Survival Outcomes for Specific Molecular Subtypes: A Systematic Analysis of Publicly Available Datasets. | Cancers (Basel) | 2022 | 36551516 | PubTator, text mining | PubMed |
| Regulation of programmed cell death by Brd4. | Cell Death Dis | 2022 | 36539410 | PubTator, text mining | PubMed |
| Diagnostic, Prognostic, and Immunological Roles of FABP4 in Pancancer: A Bioinformatics Analysis. | Comput Math Methods Med | 2022 | 36532833 | PubTator, text mining | PubMed |
An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection. | Front Microbiol | 2022 | 36519165 | PubTator, text mining | PubMed |
| Identification of molecular subtypes based on liquid-liquid phase separation and cross-talk with immunological phenotype in bladder cancer. | Front Immunol | 2022 | 36518754 | PubTator, text mining | PubMed |
Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer. | Cancers (Basel) | 2022 | 36497496 | PubTator, text mining | PubMed |
| Protein Phase Separation: New Insights into Carcinogenesis. | Cancers (Basel) | 2022 | 36497453 | PubTator, text mining | PubMed |
| Principles and functions of condensate modifying drugs. | Front Mol Biosci | 2022 | 36483537 | PubTator, text mining | PubMed |
| Overcoming the cytoplasmic retention of GDOWN1 modulates global transcription and facilitates stress adaptation. | Elife | 2022 | 36476745 | PubTator, text mining | PubMed |
| Oncogene expression from extrachromosomal DNA is driven by copy number amplification and does not require spatial clustering in glioblastoma stem cells. | Elife | 2022 | 36476408 | PubTator, text mining | PubMed |
| The dynamic clustering of insulin receptor underlies its signaling and is disrupted in insulin resistance. | Nat Commun | 2022 | 36473871 | PubTator, text mining | PubMed |
| Analysis of genome-wide knockout mouse database identifies candidate ciliopathy genes. | Sci Rep | 2022 | 36456625 | PubTator, text mining | PubMed |
| Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential. | Nat Commun | 2022 | 36450752 | PubTator, text mining | PubMed |
| Gene activation guided by nascent RNA-bound transcription factors. | Nat Commun | 2022 | 36443367 | PubTator, text mining | PubMed |
| A novel prognostic model for prostate cancer based on androgen biosynthetic and catabolic pathways. | Front Oncol | 2022 | 36439479 | PubTator, text mining | PubMed |
| 1,25(OH)2D3 Promotes Macrophage Efferocytosis Partly by Upregulating ASAP2 Transcription via the VDR-Bound Enhancer Region and ASAP2 May Affect Antiviral Immunity. | Nutrients | 2022 | 36432619 | PubTator, text mining | PubMed |
| NetREX-CF integrates incomplete transcription factor data with gene expression to reconstruct gene regulatory networks. | Commun Biol | 2022 | 36418514 | PubTator, text mining | PubMed |
| PPARγ lipodystrophy mutants reveal intermolecular interactions required for enhancer activation. | Nat Commun | 2022 | 36402763 | PubTator, text mining | PubMed |
| Placental transcriptional signatures associated with cerebral white matter damage in the neonate. | Front Neurosci | 2022 | 36389237 | PubTator, text mining | PubMed |
| The evolution and polymorphism of mono-amino acid repeats in androgen receptor and their regulatory role in health and disease. | Front Med (Lausanne) | 2022 | 36388907 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5469/papers?page=20